QuidelOrtho Science BYTES Podcast

This episode features Dr. Terry O’Neil, President and Medical Director of Urgent Care Pros, discussing why testing is essential when symptoms overlap during respiratory season. With conditions like strep, flu, RSV and COVID-19 often appearing similar at the outset, timely diagnostics provide clarity for both treatment and prevention.

About Our Speaker: 

Dr. O’Neil is a board-certified ER doctor and the president and medical director of Urgent Care Pros, a group of walk-in clinics providing fast and easy access to quality care. He has over 20 years of emergency room experience and a deep commitment to caring for patients. A graduate of Columbia University, Dr. O’Neil recognized the need for fast, efficient and specialized care in both urgent care and occupational health settings, which led him to establish Urgent Care Pros in January 2020. His approach reflects the mission of Urgent Care Pros, that is to provide unparalleled customer service and specialized health support in an affordable manner, ensuring patients receive the care they need when they need it most. Beyond his clinical work, Dr. O’Neil enjoys traveling, skiing and staying active through fitness, bringing the same energy and commitment to his personal life as he does to caring for his patients.

Our 50th episode of QuidelOrtho Science Bytes features Dr. Jonathan Temte, a leading public health expert, discussing how schools, families, and healthcare providers can stay ahead of respiratory illnesses this school year. As students return to classrooms, familiar viruses like flu, RSV, and COVID-19 often resurge.

Dr. Temte explains why symptoms alone can’t reliably distinguish between these illnesses and how rapid diagnostics are essential for early detection, accurate treatment, and preventing further spread. 

About Our Speaker: 

Dr. Temte joined the Department of Family Medicine and Community Health faculty at the University of Wisconsin-Madison in 1993. He is a professor of family medicine and community health and the Associate Dean for Public Health and Community Engagement for the University of Wisconsin School of Medicine and Public Health. Dr. Temte received his BA from Luther College, an MS in Biological Oceanography from Oregon State University, and his PhD in Zoology and Minor in Epidemiology from the University of Wisconsin. He pursued his medical training at the University of Wisconsin Medical School, where he received his MD. Dr. Temte also served as the Director of the Wisconsin Research and Education Network from 2000 to 2005. He chaired the American Academy of Family Physicians Commission on Science in 2008, the AAFP, and he currently chairs the Wisconsin Council on Immunization Practices. He also served as AAFP liaison to the Advisory Committee on Immunization Practices from 2004 to 2008, where he was appointed a voting member from 2008 to 2015 and served as chair from 2012 to 2015. Dr. Temte has also been active on pandemic influenza and bioterrorism working groups for the state of Wisconsin. In addition to his outstanding credentials, Dr. Temte's research interests include respiratory viruses, influenza, COVID-19, schools, and immunization policy.

In this episode, you'll hear a conversation with our own Vonda McAllister about the critical role of rapid diagnostic testing in helping prevent drug overdose deaths. Discover how early detection in emergency departments enables timely interventions when patients present with altered mental status or respiratory distress. The discussion explores the evolving landscape of substance abuse in 2025, including synthetic opioids like fentanyl, emerging threats like xylazine ("tranq") and the challenges of polydrug use, creating unpredictable and potentially fatal combinations.

About Our Speaker: 

Vonda McAllister, Director of Global Product Management. Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.

In this episode, you'll hear a conversation with transfusion medicine expert Michelle Mullens about how blood donation underpins patient health and the critical role it plays in healthcare. Discover how donated blood is vital not only for trauma care, but also for cancer treatments, chronic illnesses like sickle cell disease, and a wide range of surgeries. The discussion explores the growing challenges of blood supply shortages, the importance of specialized blood types, and how automation in blood banks is helping labs maintain safety and efficiency despite staffing pressures. Learn how each donation makes a difference and why maintaining a robust blood supply is essential for patient care and safety.

About our speaker: 

Global Portfolio Marketing Manager for Transfusion Medicine, QuidelOrtho

Before beginning her career on the vendor side with QuidelOrtho, Michelle was a senior medical technologist at Baptist Health, serving in leadership roles in transfusion medicine and immunohematology for nearly 30 years. With QuidelOrtho, Michelle has served as a technical specialist, business development consultant and clinical science liaison before taking on her current role.

In this episode, you'll hear a conversation with three women's health experts about how early diagnostic testing is transforming care for heart disease, STIs, and preeclampsia. Discover how proactive screening empowers women, supports personalized care, and helps shift healthcare from reaction to prevention.

About Our Speakers: 

Dr. Lindy Crimmins, Global Medical Affairs Manager. Lindy's clinical experience spans from emergency medicine to critical and primary care. Currently, she is responsible for providing medical support for the QuidelOrtho acute care menu throughout the product lifecycle. Lindy is passionate about education, testing guideline updates and assay utilization to drive improved patient-centered outcomes.

Dr. Rea Castro, Director of Medical Affairs. Rea is a seasoned medical professional with extensive experience in pharmaceutical clinical development, biotechnology and diagnostic product development across multiple therapeutic areas, including immunology, oncology and women's health. She is currently a cross-functional leader in medical affairs and is committed to advancing healthcare outcomes through innovative research, quality healthcare delivery and rigorous safety standards.

Vonda McAllister, Director of Global Product Management. Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.

In this episode, we spotlight the essential yet often-overlooked role of medical laboratory technologists – the backbone of today’s healthcare. With 70% of clinical decisions relying on lab results, these professionals face challenges including staffing shortages, rising diagnostic demands, burnout and low compensation. We explore what's driving the crisis and, more importantly, what can be done to solve it. 

About Our Speaker: 

Katy Marcum

Global Head of Clinical Labs Business Unit

QuidelOrtho

Katy is responsible for leading innovation and commercial success of the business unit worldwide, including strategic direction and solutions development for laboratory diagnostics. In her more than 13 years in the clinical laboratory and invitro diagnostics industry, Katy has served in corporate leadership roles and in the lab with top-tier hospitals, including specimen processing and registration, core lab generalists, and microbiology and serology.

This episode discusses the growing threat of sepsis, a life-threatening condition caused by the body's overwhelming response to an infection. It explores the connection between the rise in sepsis cases and the increasing problem of antibiotic resistance, highlighting the importance of effective diagnostic tools and antibiotic stewardship programs in combating this public health challenge.

About Our Speaker:

Dr. Mike Broyles

With more than 30 years of experience as a hospital pharmacy and laboratory director, Dr. Broyles is a leading expert on sepsis and the clinical use of drugs with a focus on antimicrobial stewardship. Prior to joining Thermo Fisher Scientific, Dr. Broyles was a consultant for over 25 years working with a large independent hospital network as pharmacy advisor chairman focused on developing and implementing hospital-wide clinical initiatives. Dr. Broyles has worked passionately throughout his career to define effective protocols and decision support processes in patient management and the use of diagnostic technology to help clinicians improve outcomes through better clinical care.

In this episode, we’ll discuss the importance of cardiac testing at the point of care with two renowned experts on the topic, doctors Martin Than and Paul Collinson. Both of our guests today have extensive experience on the front lines of patient care and have witnessed firsthand how point-of-care testing can save time and save lives.

About our speakers: 

Doctor Martin Than currently holds several positions in the field, including consultant specialists and director of research for the emergency department at Christchurch Hospital in New Zealand. He has authored 187 peer-reviewed journal articles on emergency medicine, cardiac care and diagnostics. Doctor Than is recognized worldwide for his research on the rapid diagnosis of acute coronary syndrome. 

In this episode, we’ll explore how quality performance metrics are transforming clinical laboratory operations and why measuring the details – from accuracy to turnaround times – are essential for improving everything from test results to patient care. 

About Our Speaker: 

Johanna Miller, Global Product Manager for QuidelOrtho. Johanna brings a wealth of expertise working with laboratory metrics. She also has a strong background in data science, and she recently published a peer-reviewed article on a novel approach to leveraging big data to calculate Sigma metrics using input from real-world clinical laboratories. Johanna has also worked closely with lab teams to build the discipline to provide metrics they can use to improve their performance. She's passionate about helping lab staff achieve excellence through data and innovation, and today she'll share her insights on how metrics can help teams navigate challenges, prioritize improvements and ultimately deliver the best possible patient outcomes.

Rh disease remains a significant health challenge, particularly impacting expectant mothers and their newborns. In this episode of Science Bytes, Dr. Steven Spitalnik discusses the milestones in Rh disease treatment, the ongoing challenges and future opportunities to combat this condition.

About our Speaker

Dr Spitalnik, MD is a Professor in the Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University, and a member of the Medical Staff at New York Presbyterian/Columbia.  He has authored over 250 publications and served as an investigator on ~30 grants and contracts including Principal investigator on ~20 of those grants. Additionally, he has sponsored more than 15 Training Grants.  Dr. Spitalnik is a member of multiple professional societies, including the Association for the Advancement of Blood and Biotherapies (AABB) and the International Society for Blood Transfusion (ISBT). He has served on multiple committees within these organizations and was on the Board of Directors for the AABB. He has received multiple society awards and was elected to the Hall of Fame of the AABB Foundation (previously the National Blood Foundation). Dr. Spitalnik is the Founding Member and Executive Director of the Worldwide Initiative for Rh Disease Eradication (WIRhE).